GlaxoSmithKline (GSK) plc announced that it has reached an agreement with XenoPort, Inc., to terminate their collaboration concerning Horizant (gabapentin...
The FDA has approved Horizant (gabapentin enacarbil) extended-release tablets, from GlaxoSmithKline / XenoPort, for Postherpetic Neuralgia in adults. Approval is...
Arbor Pharmaceuticals, and XenoPort, Inc.announced that they have signed a definitive agreement under which Arbor will acquire XenoPort for $7.03...